Skip to content

Study to Enhance Motor Acute Recovery With Intensive Training After Stroke

Study to Enhance Motor Acute Recovery With Intensive Training After Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02292251
Acronym
SMARTS2
Enrollment
32
Registered
2014-11-17
Start date
2015-05-31
Completion date
2018-04-30
Last updated
2018-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, Transcranial direct current stimulation

Brief summary

Stroke often results in limitation of arm movements, from which many people do not fully recover. We believe that early and intensive therapy is important to enhance recovery of arm movements after stroke. We are doing this research study to see how much arm movements improve with intensive therapy in patients have had a stroke in the past 6 weeks.

Interventions

BEHAVIORALDevice-assisted therapy
BEHAVIORALTherapy-based occupational therapy

Sponsors

Columbia University
CollaboratorOTHER
University of Zurich
CollaboratorOTHER
James S McDonnell Foundation
CollaboratorOTHER
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age over 21 years 2. Ischemic stroke confirmed by CT or MRI within the previous 6 weeks 3. No history of prior ischemic or hemorrhagic stroke with associated motor deficits (prior stroke with no motor symptoms is allowed) 4. Residual unilateral arm weakness with Fugl-Meyer Upper Extremity (FM-UE) score 6-40 at time of enrollment. 5. Ability to give informed consent and understand the tasks involved.

Exclusion criteria

1. Space-occupying hemorrhagic transformation or associated intracranial hemorrhage. 2. Arm impairment that is too severe or too mild on day of baseline testing just prior to beginning of the study intervention. 3. Recent botox injection to upper limb or planned botox injection over the course of the 7-month study duration. 4. Cognitive impairment, with score on Montreal Cognitive Assessment (MoCA) ≤ 20. 5. History of physical or neurological condition that interferes with study procedures or assessment of motor function (e.g. severe arthritis, severe neuropathy, Parkinson's disease). 6. Inability to sit in a chair and perform upper limb exercises for one hour at a time. 7. Participation in another upper extremity rehabilitative therapy study during the study period. 8. Terminal illness 9. Social and/or personal circumstances that interfere with ability to return for therapy sessions and follow up assessments.

Design outcomes

Primary

MeasureTime frameDescription
Fugl-Meyer Upper Extremity (FM-UE)from baseline to day 3 post-trainingChange in arm impairment, measured by FM-UE

Secondary

MeasureTime frameDescription
Fugl-Meyer Upper Extremity (FM-UE)from baseline to day 90 post-trainingChange in arm impairment, measured by FM-UE

Countries

Switzerland, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026